Systems Biology Approach for Cancer Vaccine Development and Evaluation
Open Access
- 14 July 2015
- Vol. 3 (3), 544-555
- https://doi.org/10.3390/vaccines3030544
Abstract
Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy. The newly developed high throughput technologies and computational tools are instrumental to this aim allowing the identification of more specific antigens and the comprehensive analysis of the innate and adaptive immunities. Here, we review the potentiality of systems biology in providing novel insights in the mechanisms of the action of vaccines to improve their design and effectiveness.Keywords
Funding Information
- European Union (602893)
This publication has 69 references indexed in Scilit:
- Antigen-specific T cell phenotyping microarrays using grating coupled surface plasmon resonance imaging and surface plasmon coupled emissionBiosensors and Bioelectronics, 2012
- Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyThe Lancet Infectious Diseases, 2011
- Systems biology of vaccination for seasonal influenza in humansNature Immunology, 2011
- Novel Cellular Microarray Assay for Profiling T-Cell Peptide Antigen SpecificitiesJournal of Proteome Research, 2010
- Response definition criteria for ELISPOT assays revisitedCancer Immunology, Immunotherapy, 2010
- Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genesHuman Genetics, 2009
- Molecular immune signatures of HIV-1 vaccines in human PBMCsFEBS Letters, 2009
- Measuring Antigen-Specific Immune Responses, 2008 updateCytometry Part A, 2008
- Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary resultsVaccine, 2008
- Stage‐specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesisGenes, Chromosomes and Cancer, 2006